- In the
management of Parkinson's disease, due to the
chronic nature of Parkinson's
disease (PD), a broad-based
program is
needed that
includes patient...
- Long-term
physiotherapy (greater than six months)
reduces the need for
antiparkinsonian medication;
multidisciplinary rehabilitation programs combined with...
-
disease for just a
short period of time.
Clinical drugs used as an
antiparkinsonian agent such as
Trihexyphenidyl are
known to
create tactile hallucinations...
-
Hypokinesia and rigidity,
especially in
juvenile cases, can be
treated with
antiparkinsonian drugs, and
myoclonic hyperkinesia can be
treated with
valproic acid...
- C. G.; Klawans, H. L.; Thiessen, B. (1989). "Hyper****uality with
antiparkinsonian therapy".
Clinical Neuropharmacology. 12 (5): 375–383. doi:10...
-
Levodopa was
first synthesized and
isolated in the
early 1910s. The
antiparkinsonian effects of
levodopa were
discovered in the 1950s and 1960s. Following...
- that memantine,
along with amantadine, has been
widely used as an
antiparkinsonian agent since at
least 1994.
Although amantadine and
memantine have fairly...
- is an
antihistamine and
anticholinergic used as an
antipruritic and
antiparkinsonian agent. It is an
analog of diphenhydramine.
Bazex A,
Dupre A, Christol...
- for
prophylaxis against the
influenza virus A in 1966. In 1968, its
antiparkinsonian effects were
serendipitously discovered. In 1973, the Food and Drug...
- purposes.
These include anesthetics, analgesics,
anticonvulsant and
antiparkinsonian drugs as well as
medications used to
treat neuropsychiatric disorders...
